Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 110,707 | 100,156 | 63,333 | 44,068 | 35,777 |
| Marketable Securities | 27,751 | 6,750 | N/A | N/A | N/A |
| Receivables | 21,652 | 17,152 | 18,737 | 21,463 | 17,308 |
| Inventories | 14,938 | 12,407 | 10,997 | 8,284 | 7,303 |
| Income taxes - deferred | N/A | N/A | 659 | 2,032 | 1,919 |
| TOTAL | $176,433 | $137,836 | $94,592 | $77,385 | $64,138 |
| Non-Current Assets | |||||
| PPE Net | 40,108 | 31,669 | 32,939 | 35,113 | 36,470 |
| Intangibles | 19,138 | 23,234 | 28,442 | 29,401 | 32,032 |
| Other Non-Current Assets | 69 | 69 | 69 | 171 | 205 |
| TOTAL | $59,315 | $54,972 | $61,450 | $64,685 | $68,707 |
| Total Assets | $235,748 | $192,808 | $156,042 | $142,069 | $132,844 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 1,600 | 1,600 |
| Accounts payable and accrued liabilities | 8,302 | 1,201 | 2,794 | 2,342 | 4,300 |
| Accrued Expenses | 4,778 | 4,772 | 5,538 | 5,837 | 5,322 |
| TOTAL | $17,278 | $5,973 | $9,283 | $14,453 | $14,538 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 102 | N/A | 8,000 | 9,600 |
| Deferred Revenues | N/A | N/A | 180 | 2,875 | 2,867 |
| Other Non-Current Liabilities | 781 | 894 | 1,134 | 1,541 | 1,549 |
| TOTAL | $7,622 | $8,737 | $11,125 | $18,691 | $23,543 |
| Total Liabilities | $24,900 | $14,710 | $20,408 | $33,144 | $38,082 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,330 | 14,546 | 14,325 | 13,919 | 13,669 |
| Common Shares | 150 | 149 | 143 | 139 | 136 |
| Retained earnings | 135,662 | 104,904 | 66,584 | 46,010 | 34,252 |
| Other shareholders' equity | -6,649 | -4,495 | -1,699 | -2,655 | -3,067 |
| TOTAL | $210,848 | $178,098 | $135,634 | $108,925 | $94,763 |
| Total Liabilities And Equity | $235,748 | $192,808 | $156,042 | $142,069 | $132,845 |